Table 2.
Antibiogram, antimicrobial resistance genes and replicons results of conjugation and transformation.
| ID | Species | AK | AMC | AMP | ATM | FEP | CTX | CAZ | CIP | COL | ERT | CN | LEV | MEM | TZP | TOB | AMR | Replicon |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J62 | E. coli | < = 8 S | < 32 S | < 8 S | < 1 S | < 8 S | < 32 S | < 32 S | < 0.06 S | < 2 S | 0.25 S | < 2 S | < 0.5 S | < 2 S | < 8 S | < 2 S | ND | ND |
| TOP10 | E. coli | < = 8 S | < 32 S | < 8 S | < 1 S | < 8 S | < 32 S | < 32 S | < 0.06 S | < 2 S | 0.25 S | < 2 S | < 0.5 S | < 2 S | < 8 S | < 2 S | ND | ND |
| 6370 | E. asburiae | > 16 R | > 32 R | > 8 R | > 16 R | > 8 R | > 32 R | > 32 R | < 0.06 S | > 4 R | > 1 R | > 4 R | < 0.5 S | > 32 R | > 16 R | > 4 R | blaNDM, blaVIM | IncA/C, IncN |
| J62*6370 | E. coli | < = 8 S | > 32 R | > 8 R | 4 I | > 8 R | > 32 R | > 32 R | < 0.06 S | < 2 S | > 1 R | > 4 R | < 0.5 S | > 32 R | > 16 R | > 4 R | blaNDM, blaVIM | IncA/C, IncN |
| TOP10*6370 | E. coli | < = 8 S | > 32 R | > 8 R | 4 I | > 8 R | > 32 R | > 32 R | < 0.06 S | < 2 S | > 1 R | > 4 R | < 0.5 S | > 32 R | > 16 R | > 4 R | blaNDM, blaVIM | IncA/C, IncN |
| 7108 | E. asburiae | > 16 R | > 32 R | > 8 R | > 16 R | > 8 R | > 32 R | > 32 R | < 0.06 S | > 4 R | > 1 R | > 4 R | < 0.5 S | > 32 R | > 16 R | > 4 R | blaNDM, blaVIM | IncA/C, IncN |
| J62*7108 | E. coli | > 16 R | > 32 R | > 8 R | < = 1 S | > 8 R | > 32 R | > 32 R | < 0.06 S | < 2 S | > 1 R | > 4 R | < 0.5 S | 16 R | > 16 R | > 4 R | blaNDM | IncN |
| TOP10*7108 | E. coli | > 16 R | > 32 R | > 8 R | < = 1 S | > 8 R | > 32 R | > 32 R | < 0.06 S | < 2 S | > 1 R | > 4 R | < 0.5 S | > 32 R | > 16 R | > 4 R | blaNDM | IncN |
AK: amikacin; AMC: amoxicillin/clavulanic acid; ATM: aztreonam; FEP: cefepime; CTX: cefotazime; CAZ: ceftazidime; CIP: ciprofloxacin; COL: colistin; ERT: ertapenem; CN: gentamicin; LEV: levofloxacin; MEM: meropenem; TZP: piperacillin/tazobactam; TOB: tobramycin.
AMR: antimicrobial resistance genes; ND: not detected.